Peptides Community
Administration science
S 0022026-08-06

Approved-product label index

This index links to current official US (FDA) and EU (EMA) / UK (MHRA) product labeling for selected approved peptide products. It is not exhaustive. Preparation, administration, and dose must follow the exact, current product-specific labeling in the jurisdiction of use. Trained health-care professionals and the exact product label govern preparation and use. This index provides high-level route/form summaries only; it does not reproduce procedural steps.

Index

INN / brand (example)ClassFDA label (DailyMed setid or Drugs@FDA)EU/UK labelRoute / form
Abaloparatide / TymlosParathyroid hormone receptor agonisthttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=712143d9-e21e-4013-bb3b-3426a21060a8N/A (approved in US only)SC injection, multi-dose prefilled pen
Bivalirudin / AngiomaxDirect thrombin inhibitorFDA Angiomax label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020873s036lbl.pdfN/AIV injection/infusion, lyophilized powder for reconstitution
Buserelin / SuprefactGnRH agonistN/AUK eMC: https://www.medicines.org.uk/emc/product/1156SC injection, intranasal spray
Calcitonin (salmon) / MiacalcinCalcitonin analoguehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=26caf31f-7f7c-48a8-a1ac-35d2ceefda2bUK eMC: https://www.medicines.org.uk/emc/product/385SC/IM injection, solution
Cetrorelix / CetrotideGnRH antagonisthttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aca7768e-28a7-4027-b1d8-e66247665f79EMA: https://www.ema.europa.eu/en/medicines/human/EPAR/cetrotideSC injection, lyophilized powder for reconstitution
Degarelix / FirmagonGnRH antagonisthttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab11dd8a-0fd9-4013-89ab-e114557c7e4bEMA: https://www.ema.europa.eu/en/medicines/human/EPAR/firmagonSC injection, lyophilized powder for reconstitution
Desmopressin / DDAVP injectionVasopressin analoguehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=651f6fee-a2c7-431b-8d5d-58b156c72244N/A (nationally authorized in EU — consult national register)IV/SC injection, solution
Dulaglutide / TrulicityGLP-1 receptor agonisthttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=463050bd-2b1c-40f5-b3c3-0a04bb433309EMA: https://www.ema.europa.eu/en/medicines/human/EPAR/trulicitySC injection, single-dose prefilled pen
Enfuvirtide / FuzeonHIV fusion inhibitorFDA Fuzeon label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021481s032lbl.pdfEMA: https://www.ema.europa.eu/en/medicines/human/EPAR/fuzeonSC injection, lyophilized powder for reconstitution
Exenatide / ByettaGLP-1 receptor agonisthttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d03c03-ebf7-418d-88a8-533eabd2ee4fEMA: https://www.ema.europa.eu/en/medicines/human/EPAR/byettaSC injection, multi-dose prefilled pen
Glucagon / GlucaGenGlucagonFDA GlucaGen label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020918s056lbl.pdfN/A (nationally authorized in EU — consult national register)SC/IM/IV injection, lyophilized powder for reconstitution
Goserelin / ZoladexGnRH agonisthttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=294b168b-6e5f-4db9-bf70-d599271458b3N/A (nationally authorized in EU — consult national register)SC injection, pre-filled syringe (depot implant)
Insulin aspart / NovoLogRapid-acting insulinhttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5EMA: https://www.ema.europa.eu/en/medicines/human/EPAR/novorapidSC injection, multi-dose vial/prefilled pen/pump
Insulin glargine / LantusLong-acting insulinhttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5e07a0c-7e14-4756-9152-9fea485d654aEMA: https://www.ema.europa.eu/en/medicines/human/EPAR/lantusSC injection, multi-dose vial/prefilled pen
Lanreotide / Somatuline DepotSomatostatin analoguehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e4a41fd-a753-4362-87ee-8cc56ed3660dN/A (nationally authorized in EU — consult national register)Deep SC injection, prefilled syringe
Leuprolide / Lupron DepotGnRH agonisthttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbc8f94e-7330-4465-05ad-16d64493a5ddN/A (nationally authorized in EU — consult national register)IM injection, PLGA microspheres for reconstitution
Liraglutide / VictozaGLP-1 receptor agonisthttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a9ef4ea-c76a-4d34-a604-27c5b505f5a4EMA: https://www.ema.europa.eu/en/medicines/human/EPAR/victozaSC injection, multi-dose prefilled pen
Octreotide / Sandostatin and Sandostatin LAR DepotSomatostatin analogueInjection: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e2c9856-1836-49f0-9472-4dbeeb408f39; LAR: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0b7fe9e-7000-4b79-ba3b-291ce92c14f9N/A (nationally authorized in EU — consult national register)SC/IV injection, multi-dose vial; IM depot kit
Pramlintide / SymlinAmylin analoguehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4aea30ff-eb0d-45c1-b114-3127966328ffN/ASC injection, multi-dose prefilled pen
Semaglutide / OzempicGLP-1 receptor agonisthttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79EMA: https://www.ema.europa.eu/en/medicines/human/EPAR/ozempicSC injection, multi-dose prefilled pen
Somatropin / GenotropinGrowth hormonehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ffebf88b-d257-4542-9808-74d9b7167765N/A (nationally authorized in EU — consult national register)SC injection, dual-chamber cartridge / lyophilized powder for reconstitution
Teriparatide / ForteoParathyroid hormone analoguehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aae667c5-381f-4f92-93df-2ed6158d07b0EMA: https://www.ema.europa.eu/en/medicines/human/EPAR/forsteoSC injection, multi-dose prefilled pen
Tesamorelin / Egrifta WRGrowth hormone releasing factor analoguehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75N/ASC injection, lyophilized powder for reconstitution
Vasopressin / VasostrictVasopressinhttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1147beb-743e-4c62-8927-91192447f8b8UK eMC: https://www.medicines.org.uk/emc/product/1816IV injection, aqueous solution

How to use this index

  1. Locate the product by its INN or brand name.

  2. Click the FDA label link (for US products) or the EU/UK label link. Each link was resolved to its exact product record as of the last_verified date; archived Drugs@FDA labels are used where DailyMed has no current brand record.

  3. For products approved in other jurisdictions (Health Canada, TGA, PMDA), consult the respective agency's drug product database.

  4. Read the entire label — especially the section titled "Dosage and Administration" (FDA) or "Posology and method of administration" (EMA SmPC) — for product-specific reconstitution, dilution, storage, and administration instructions.

Limitations

  • Not all approved peptide products are listed; this index focuses on representative products commonly referenced in the peptide space.

  • Label URLs may change when a new approval, safety update, or labeling format is issued. Verify current URL via the FDA Drugs@FDA database (https://www.accessdata.fda.gov/scripts/cder/daf/) or the EMA Medicines database (https://www.ema.europa.eu/en/medicines).

  • International nonproprietary names (INNs) are used where available; brand names may differ by jurisdiction.

  • The route/form column is a high-level summary. Full dose preparation details are in the labeled product information.

  • TYMLOS (abaloparatide) is a multi-dose prefilled pen; SYMLIN (pramlintide) is a multi-dose prefilled pen. Both were previously described as single-dose or vial presentations and have been corrected.

Sources

  1. FDA Drugs@FDA Database. https://www.accessdata.fda.gov/scripts/cder/daf/

  2. EMA Medicines Database. https://www.ema.europa.eu/en/medicines

  3. UK Electronic Medicines Compendium (emc). https://www.medicines.org.uk/emc

  4. DailyMed (NIH). https://dailymed.nlm.nih.gov/dailymed/